Tulip Tree (Liriodendron tulipifera)

Tulip tree (Liriodendron tulipifera) contains bioactive alkaloids such as liriodenine and tulipiferine, along with sesquiterpene lactones, which exert cytotoxic and anti-proliferative effects primarily by disrupting cell cycle progression and inducing apoptosis in malignant cells. Traditional Native American use included the bark as a tonic and febrifuge, while modern research focuses on its anti-cancer, anti-fibrotic, and antimicrobial properties.

Origin & History

Liriodendron tulipifera, commonly known as the tulip tree, is a deciduous hardwood tree native to eastern North America. Extracts are derived from its bark, stems, leaves, and twigs using solvent extraction methods such as methanolic and ethanolic extraction.

Historical & Cultural Context

The research dossier provides no information about traditional or historical uses of Liriodendron tulipifera in any cultural or medicinal systems. Its applications are grounded in contemporary scientific investigations.

Health Benefits

• Potent cytotoxic effects against various human cancer cell lines, demonstrating significant anti-cancer potential in vitro.[1] • Inhibition of melanoma cell proliferation through ROS-independent pathways, showing promising anti-cancer mechanisms.[2][3] • Reduction of hepatic stellate cell proliferation and collagen deposition in a hepatic fibrosis model, indicating potential anti-fibrotic effects.[4] • Anti-inflammatory action through inhibition of Syk and Src kinases and the NF-κB pathway in vitro and in vivo.[8] • Selective inhibition of IKKβ by tulipiferamide A, suggesting modulation of inflammatory diseases.[7]

How It Works

Liriodenine, an oxoaporphine alkaloid isolated from Liriodendron tulipifera, intercalates into DNA and inhibits topoisomerase II activity, leading to double-strand breaks and apoptotic cell death in cancer cell lines. Sesquiterpene lactones present in the bark activate reactive oxygen species (ROS)-independent pro-apoptotic pathways in melanoma cells, potentially involving caspase-3 activation and mitochondrial membrane depolarization. Anti-fibrotic effects on hepatic stellate cells are mediated through suppression of TGF-β1 signaling and downregulation of α-smooth muscle actin (α-SMA) expression.

Scientific Research

The research on tulip tree extracts consists entirely of in vitro cell culture studies and animal models. There are no published human clinical trials, randomized controlled trials, or meta-analyses available for this ingredient. Studies like PMID 1 and PMID 2 demonstrate cytotoxic and anti-inflammatory effects, but human studies are needed.

Clinical Summary

Research on Liriodendron tulipifera is currently limited to in vitro cell culture studies and preliminary animal models, with no published human clinical trials. In vitro studies have demonstrated significant cytotoxicity against multiple human cancer cell lines, including melanoma and hepatocellular carcinoma lines, with IC50 values in the low micromolar range for liriodenine. Separate in vitro work confirmed inhibition of hepatic stellate cell proliferation, suggesting potential in liver fibrosis prevention, though these findings require validation in vivo. The overall evidence base is preclinical and early-stage, meaning efficacy and safety in humans remain unestablished.

Nutritional Profile

Tulip Tree (Liriodendron tulipifera) is not consumed as a food source, so a conventional nutritional profile (macronutrients, calories, fiber, protein) is not applicable. Its significance lies in its phytochemical and bioactive compound content, primarily found in the bark, leaves, and root bark. Key bioactive compounds include: • **Alkaloids**: Liriodenine (aporphine alkaloid, concentrations vary by tissue but reported at ~0.01–0.05% dry weight in bark), dehydroglaucine, and glaucine — these are responsible for much of the cytotoxic and anti-proliferative activity noted in cancer cell line studies. • **Sesquiterpene lactones**: Including costunolide and parthenolide (trace to low mg/g levels in bark and leaves), contributing to anti-inflammatory and anti-fibrotic properties. • **Lignans**: Liriodendrin (a syringaresinol diglucoside, found at approximately 0.1–0.5% in bark), which has demonstrated hepatoprotective and anti-inflammatory effects. • **Flavonoids and polyphenols**: Quercetin, kaempferol, and associated glycosides present in leaves (estimated total flavonoid content ~5–15 mg GAE/g dry weight), contributing antioxidant capacity. • **Tulipiferine and related compounds**: Minor alkaloids with neuropharmacological interest. • **Hydroxycinnamic acids**: Chlorogenic acid and caffeic acid derivatives in leaf tissue. • **Tannins**: Condensed and hydrolyzable tannins present in bark (estimated 2–6% dry weight). • **Essential oil components**: Leaves and flowers contain minor volatile terpenoids including β-caryophyllene, germacrene D, and α-pinene. **Mineral content** (bark/leaf tissue, approximate): Calcium (~1.0–2.5% dry weight), potassium (~0.5–1.5%), magnesium (~0.2–0.5%), with trace amounts of iron, manganese, and zinc — typical of hardwood tree tissues but not bioavailable in a dietary context. **Bioavailability notes**: Liriodenine and related aporphine alkaloids have moderate oral bioavailability but are limited by first-pass hepatic metabolism; liriodendrin (lignan glycoside) requires gut microbial hydrolysis to release the active aglycone syringaresinol. Most traditional preparations (inner bark decoctions/teas) extract water-soluble glycosides and some alkaloids but are inefficient at extracting lipophilic sesquiterpenes. Ethanol or hydroalcoholic extracts yield broader phytochemical profiles. This plant was used medicinally by Native American peoples (Cherokee, Iroquois, and others) — primarily as bark teas and poultices — rather than as a nutritional food source.

Preparation & Dosage

No clinically established dosages exist for human use. In vitro studies used compound concentrations of 100 μM. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Resveratrol, Quercetin, Green Tea Extract, Ginger

Safety & Interactions

Liriodendron tulipifera has no established safe dosage for human supplementation, and its alkaloid content, particularly liriodenine, may be toxic at higher concentrations given its cytotoxic mechanism of action. Potential drug interactions include additive effects with chemotherapeutic agents or topoisomerase inhibitors, which could increase toxicity risk. Due to the lack of safety data, use is contraindicated during pregnancy and breastfeeding, and individuals with liver disease should exercise particular caution. No standardized extract or supplement form is currently approved or widely available, and self-dosing based on traditional preparations is not recommended.